QQQ   313.68 (+0.27%)
AAPL   122.64 (+1.36%)
MSFT   231.59 (+1.14%)
FB   258.16 (+1.36%)
GOOGL   2,020.11 (+0.21%)
AMZN   3,059.42 (+0.07%)
TSLA   674.15 (-1.18%)
NVDA   540.93 (+1.62%)
BABA   239.25 (-0.39%)
CGC   32.87 (-1.02%)
GE   12.47 (-2.27%)
MU   89.05 (+1.06%)
NIO   45.37 (-3.08%)
AMD   83.77 (+1.64%)
T   28.46 (-0.59%)
F   11.62 (-1.19%)
ACB   10.84 (+0.18%)
DIS   186.55 (-2.32%)
BA   212.90 (-1.64%)
NFLX   541.68 (-0.92%)
BAC   34.78 (-3.20%)
QQQ   313.68 (+0.27%)
AAPL   122.64 (+1.36%)
MSFT   231.59 (+1.14%)
FB   258.16 (+1.36%)
GOOGL   2,020.11 (+0.21%)
AMZN   3,059.42 (+0.07%)
TSLA   674.15 (-1.18%)
NVDA   540.93 (+1.62%)
BABA   239.25 (-0.39%)
CGC   32.87 (-1.02%)
GE   12.47 (-2.27%)
MU   89.05 (+1.06%)
NIO   45.37 (-3.08%)
AMD   83.77 (+1.64%)
T   28.46 (-0.59%)
F   11.62 (-1.19%)
ACB   10.84 (+0.18%)
DIS   186.55 (-2.32%)
BA   212.90 (-1.64%)
NFLX   541.68 (-0.92%)
BAC   34.78 (-3.20%)
QQQ   313.68 (+0.27%)
AAPL   122.64 (+1.36%)
MSFT   231.59 (+1.14%)
FB   258.16 (+1.36%)
GOOGL   2,020.11 (+0.21%)
AMZN   3,059.42 (+0.07%)
TSLA   674.15 (-1.18%)
NVDA   540.93 (+1.62%)
BABA   239.25 (-0.39%)
CGC   32.87 (-1.02%)
GE   12.47 (-2.27%)
MU   89.05 (+1.06%)
NIO   45.37 (-3.08%)
AMD   83.77 (+1.64%)
T   28.46 (-0.59%)
F   11.62 (-1.19%)
ACB   10.84 (+0.18%)
DIS   186.55 (-2.32%)
BA   212.90 (-1.64%)
NFLX   541.68 (-0.92%)
BAC   34.78 (-3.20%)
QQQ   313.68 (+0.27%)
AAPL   122.64 (+1.36%)
MSFT   231.59 (+1.14%)
FB   258.16 (+1.36%)
GOOGL   2,020.11 (+0.21%)
AMZN   3,059.42 (+0.07%)
TSLA   674.15 (-1.18%)
NVDA   540.93 (+1.62%)
BABA   239.25 (-0.39%)
CGC   32.87 (-1.02%)
GE   12.47 (-2.27%)
MU   89.05 (+1.06%)
NIO   45.37 (-3.08%)
AMD   83.77 (+1.64%)
T   28.46 (-0.59%)
F   11.62 (-1.19%)
ACB   10.84 (+0.18%)
DIS   186.55 (-2.32%)
BA   212.90 (-1.64%)
NFLX   541.68 (-0.92%)
BAC   34.78 (-3.20%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NovoCureTeleflexInsuletAbiomedFresenius SE & Co. KGaA
SymbolNASDAQ:NVCRNYSE:TFXNASDAQ:PODDNASDAQ:ABMDOTCMKTS:FSNUY
Price Information
Current Price$144.91$398.14$261.00$314.95$10.88
52 Week RangeHoldBuyHoldHoldBuy
MarketRank™
Overall Score1.52.01.31.51.6
Analysis Score1.22.62.11.20.0
Community Score2.62.22.72.62.3
Dividend Score0.01.70.00.02.5
Ownership Score1.71.70.01.70.0
Earnings & Valuation Score1.91.91.91.93.1
Analyst Ratings
Consensus RecommendationHoldBuyHoldHoldBuy
Consensus Price Target$126.00$433.60$246.50$300.00N/A
% Upside from Price Target-13.05% downside8.91% upside-5.56% downside-4.75% downsideN/A
Trade Information
Market Cap$15.16 billion$18.74 billion$17.32 billion$14.50 billion$24.21 billion
Beta1.291.140.761.411.36
Average Volume655,684202,288406,625365,30531,641
Sales & Book Value
Annual Revenue$351.32 million$2.60 billion$738.20 million$840.88 million$39.66 billion
Price / Sales41.997.1423.3116.940.61
CashflowN/A$16.07 per share$0.62 per share$5.04 per share$2.01 per share
Price / CashN/A24.77423.2062.525.40
Book Value$2.20 per share$64.35 per share$1.23 per share$23.64 per share$13.38 per share
Price / Book65.876.19212.2013.320.81
Profitability
Net Income$-7,230,000.00$461.47 million$11.60 million$203.01 million$2.11 billion
EPS($0.07)$11.15$0.19$4.74$0.94
Trailing P/E Ratio762.7251.24593.2069.2211.96
Forward P/E Ratio337.0031.55237.2764.6710.46
P/E GrowthN/A2.63N/A4.15N/A
Net Margins4.26%14.66%3.33%25.89%4.99%
Return on Equity (ROE)7.40%16.33%8.94%15.34%6.74%
Return on Assets (ROA)3.94%7.66%2.07%13.51%2.63%
Dividend
Annual PayoutN/A$1.36N/AN/A$0.17
Dividend YieldN/A0.34%N/AN/A1.56%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A12.20%N/AN/A18.09%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.63%1.55%N/A0.68%
Current Ratio4.02%2.99%6.62%6.81%1.21%
Quick Ratio3.74%1.88%5.91%6.02%0.92%
Ownership Information
Institutional Ownership Percentage71.09%89.78%N/A93.95%0.06%
Insider Ownership Percentage5.07%2.21%1.10%3.40%N/A
Miscellaneous
Employees78214,4001,3501,536309,114
Shares Outstanding101.80 million46.57 million65.93 million45.23 million2.23 billion
Next Earnings DateN/A4/28/2021 (Estimated)5/6/2021 (Estimated)4/29/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.